Latest News about NK
Recent news which mentions NK
88 Biggest Movers From Yesterday
February 24, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 23, 2021
From Benzinga
The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts
February 23, 2021
From Benzinga
The Daily Biotech Pulse: Novavax Vaccine Supply Deal, Orphan Drug Designation For Travere, COVID-19 Boost For Quidel, Opko
February 19, 2021
From Benzinga
The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal
February 17, 2021
From Benzinga
64 Biggest Movers From Friday
February 16, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
February 12, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 12, 2021
From Benzinga
The Daily Biotech Pulse: European Regulatory Nod For Xeris, Amicus Falls On Data, 4 IPOs, FDA Decision For Mallinckrodt's StrataGraft Delayed
February 12, 2021
From Benzinga
NantKwest/ImmunityBio's COVID-19 Vaccine Candidate To Be Tested For Oral And Sublingual Route Of Administration
February 12, 2021
Tickers
NK
From Benzinga
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
February 11, 2021
From Benzinga
The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs
February 10, 2021
From Benzinga
The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement
February 09, 2021
From Benzinga
The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet's Spin-Off, IPO Deluge Hits Street
February 05, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
February 04, 2021
From Benzinga
The Daily Biotech Pulse: Novartis COVID-19 Drug Readout, Merck And Roche Earnings, 3 IPOs
February 04, 2021
From Benzinga
The Daily Biotech Pulse: Amgen Earnings, GSK-CureVac Vaccine Collaboration, Mallinckrodt FDA Decision
February 03, 2021
From Benzinga
The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO
January 28, 2021
From Benzinga
The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
January 15, 2021
From Benzinga
70 Biggest Movers From Yesterday
January 15, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 14, 2021
From Benzinga
52 Stocks Moving In Thursday's Mid-Day Session
January 14, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 14, 2021
From Benzinga
The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates
January 14, 2021
From Benzinga
36 Stocks Moving in Thursday's Pre-Market Session
January 14, 2021
From Benzinga
From Benzinga
Cramer Shares His Thoughts On AT&T, Nantkwest And More
January 05, 2021
From Benzinga
Here's a Cancer-Killing Stock to Buy for 2021
December 30, 2020
From Motley Fool
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|
|
|
|